NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors.
about
NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
NKX2.2, PDX-1 and CDX-2 as pot ...... ntiated neuroendocrine tumors.
@en
NKX2.2, PDX-1 and CDX-2 as pot ...... ntiated neuroendocrine tumors.
@nl
type
label
NKX2.2, PDX-1 and CDX-2 as pot ...... ntiated neuroendocrine tumors.
@en
NKX2.2, PDX-1 and CDX-2 as pot ...... ntiated neuroendocrine tumors.
@nl
prefLabel
NKX2.2, PDX-1 and CDX-2 as pot ...... ntiated neuroendocrine tumors.
@en
NKX2.2, PDX-1 and CDX-2 as pot ...... ntiated neuroendocrine tumors.
@nl
P2093
P2860
P1433
P1476
NKX2.2, PDX-1 and CDX-2 as pot ...... ntiated neuroendocrine tumors.
@en
P2093
Abiy Ambaye
Alexa M Buskey
James G Liu
Jeannette M Mitchell
Maura M Barry
Michelle X Yang
Richard Zubarik
Ryan F Coates
Steven Ades
Valerie Cortright
P2860
P2888
P356
10.1186/S40364-018-0129-8
P577
2018-04-18T00:00:00Z
P6179
1103471898